Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evoked cough response on emergence
ACTRN12616000116426Phase 4Completed
- Sponsor
- Dr Loh Pui San
- Start
- Nov 2015
- Modality
- Small Molecules, Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems
- Countries
- 1
01
Overview
Phase 4, single-blind trial of Sugammadex, neostigmine, glycopyrronium and rocuronium (3 arms), sponsored by Dr Loh Pui San. Primary endpoint: Incidence of severe cough on emergence. Started Nov 2015; status: completed.
02
Drugs
Sugammadexneostigmineglycopyrroniumrocuronium
Beyond the preview
Go deeper on ACTRN12616000116426.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12616000116426.